Article Information
History
- October 7, 2019.
Article Versions
- Version 1 (April 12, 2019 - 08:02).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Pingping Mao1,2,3,4,£,
- Ofir Cohen1,2,3,4,£,
- Kailey J. Kowalski1,2,3,4,
- Justin G. Kusiel1,2,3,4,
- Jorge E. Buendia-Buendia1,2,3,4,
- Michael S. Cuoco7,
- Pedro Exman2,
- Seth A. Wander1,2,3,4,5,
- Adrienne G. Waks1,2,3,4,5,
- Utthara Nayar1,2,3,4,
- Jon Chung6,
- Samuel Freeman4,
- Orit Rozenblatt-Rosen7,
- Vincent A. Miller6,
- Federica Piccioni4,
- David E. Root4,
- Aviv Regev7,8,
- Eric P. Winer2,3,5,
- Nancy U. Lin2,3,5 and
- Nikhil Wagle1,2,3,4,5,*
- 1Center for Cancer Precision Medicine, Dana-Farber Cancer Institute, Boston, MA
- 2Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
- 3Harvard Medical School, Boston, MA
- 4Broad Institute of MIT and Harvard, Cambridge, MA
- 5Department of Medicine, Brigham and Women’s Hospital, Boston, MA
- 6Foundation Medicine, Inc. Cambridge, MA
- 7Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge MA
- 8Howard Hughes Medical Institute and Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA
- ↵*Address correspondence to: Nikhil Wagle, MD, Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Dana 820A, Boston, MA 02215, Phone: 617-632-6419, e-mail: nikhil_wagle{at}dfci.harvard.edu
↵£ These authors contributed equally